SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002017897-24-000001
Filing Date
2024-04-03
Accepted
2024-04-03 17:07:25
Documents
1
Effectiveness Date
2024-04-03
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13162
  Complete submission text file 0002017897-24-000001.txt   14382
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-509579 | Film No.: 24819889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)